Jeffrey A Kline Selected Research

Pulmonary Embolism

12/2022	An adaptive clinical trial design to identify the target dose of tenecteplase for treatment of acute pulmonary embolism.
1/2022	Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysis.
1/2022	Modulation of soluble guanylate cyclase ameliorates pulmonary hypertension in a rat model of chronic thromboembolic pulmonary hypertension by stimulating angiogenesis.
1/2021	Outpatient Treatment of Low-risk Pulmonary Embolism in the Era of Direct Oral Anticoagulants: A Systematic Review.
1/2021	Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial.
11/2020	Fibrinolytics for the treatment of pulmonary embolism.
1/2020	Inhaled nitric oxide to control platelet hyper-reactivity in patients with acute submassive pulmonary embolism.
1/2020	Over-Testing for Suspected Pulmonary Embolism in American Emergency Departments: The Continuing Epidemic.
1/2020	Effect of metabolic syndrome on mean pulmonary arterial pressures in patients with acute pulmonary embolism treated with catheter-directed thrombolysis.
1/2019	Inhaled nitric oxide to treat intermediate risk pulmonary embolism: A multicenter randomized controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey A Kline Research Topics

Disease

59	Pulmonary Embolism 12/2022 - 02/2002
18	Venous Thromboembolism 01/2022 - 05/2005
16	Sepsis (Septicemia) 12/2018 - 06/2003
13	Septic Shock (Toxic Shock Syndrome) 12/2018 - 06/2003
12	Inflammation (Inflammations) 12/2017 - 08/2006
9	Chest Pain (Chest Pains) 01/2021 - 07/2006
8	Pulmonary Hypertension 01/2022 - 08/2006
7	Ischemia 01/2016 - 05/2003
7	Shock 10/2015 - 07/2007
7	Infections 06/2013 - 08/2007
6	Neoplasms (Cancer) 01/2022 - 04/2010
6	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 04/2010
6	Dyspnea (Shortness of Breath) 01/2019 - 03/2014
6	Hemorrhage 01/2018 - 04/2002
5	Hemolysis 07/2017 - 12/2011
5	Hypotension (Low Blood Pressure) 07/2013 - 01/2004
4	Renal Insufficiency (Renal Failure) 01/2022 - 01/2010
4	Acute Coronary Syndrome 01/2021 - 07/2006
4	Heart Arrest (Cardiac Arrest) 01/2019 - 04/2002
3	Thrombosis (Thrombus) 01/2022 - 05/2010
3	COVID-19 01/2022 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2012
3	Hypertension (High Blood Pressure) 01/2020 - 11/2003
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 11/2009
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2018 - 05/2015
2	Thromboembolism 04/2018 - 02/2010
2	Heart Failure 01/2018 - 11/2003
2	Right Ventricular Dysfunction 07/2017 - 02/2015
2	Necrosis 01/2017 - 10/2003
2	Wounds and Injuries (Trauma) 10/2012 - 06/2010
2	Hypoxia (Hypoxemia) 04/2010 - 06/2008
2	Fatigue 06/2007 - 05/2003
1	Pathologic Constriction (Stenosis) 01/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2021

Drug/Important Bio-Agent (IBA)

18	fibrin fragment D (D-dimer)IBA 01/2022 - 02/2002
16	Lactic Acid (Lactate)FDA LinkGeneric 12/2018 - 05/2003
10	Biomarkers (Surrogate Marker)IBA 12/2017 - 11/2006
7	AnticoagulantsIBA 01/2021 - 05/2012
7	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 01/2020 - 05/2010
6	Proteins (Proteins, Gene)FDA Link 01/2014 - 06/2003
5	Vitamin K FDA Link 01/2021 - 02/2016
5	RivaroxabanIBA 01/2018 - 07/2015
5	Hemoglobins (Hemoglobin)IBA 02/2016 - 12/2011
5	ChemokinesIBA 03/2010 - 11/2003
4	Tenecteplase FDA Link 12/2022 - 04/2007
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 06/2014
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 11/2003
4	Heparin (Liquaemin)FDA LinkGeneric 07/2015 - 01/2006
3	Soluble Guanylyl CyclaseIBA 01/2022 - 12/2011
3	ORALIT (ORS)IBA 01/2022 - 10/2015
3	Polystyrenes (Polystyrene)IBA 01/2022 - 06/2003
3	TroponinIBA 01/2021 - 08/2008
3	Carbon DioxideIBA 01/2019 - 07/2006
3	Carnitine (L-Carnitine)FDA LinkGeneric 12/2018 - 08/2014
3	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 06/2008
3	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2018 - 05/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2017 - 09/2011
3	Oxygen (Dioxygen)IBA 01/2017 - 07/2006
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2016 - 04/2007
3	Peroxidase (Myeloperoxidase)IBA 02/2010 - 07/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2018 - 06/2008
2	Prothrombin (Factor II)IBA 04/2018 - 06/2006
2	ProcalcitoninIBA 05/2017 - 07/2007
2	salicylhydroxamic acid (SHAM)IBA 05/2015 - 02/2010
2	EnzymesIBA 02/2015 - 06/2008
2	Saline SolutionIBA 08/2014 - 05/2003
2	Arginine (L-Arginine)FDA Link 03/2014 - 02/2012
2	HaptoglobinsIBA 01/2014 - 07/2012
2	BAY 41-8543IBA 04/2013 - 12/2011
2	Troponin IIBA 06/2012 - 07/2007
2	CreatinineIBA 06/2012 - 01/2010
2	ArginaseIBA 02/2012 - 08/2011
2	Estrogens (Estrogen)FDA Link 06/2010 - 04/2010
2	Pharmaceutical PreparationsIBA 09/2009 - 05/2003
2	C-Reactive ProteinIBA 09/2008 - 07/2006
2	Pyruvic Acid (Pyruvate)IBA 06/2007 - 05/2003
2	Oxidoreductases (Dehydrogenase)IBA 06/2007 - 05/2003
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	Semaxinib (SU5416)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2022
1	Coloring Agents (Dyes)IBA 11/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2020

Therapy/Procedure

17	Therapeutics 01/2022 - 08/2005
13	Resuscitation 01/2019 - 04/2002
8	Microspheres (Microsphere) 01/2022 - 04/2002
7	Length of Stay 01/2022 - 11/2004
3	Induced Hypothermia 01/2019 - 01/2018
3	Early Goal-Directed Therapy 06/2011 - 08/2007
3	Ligation 10/2003 - 05/2003
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 10/2015
2	Airway Management 12/2012 - 08/2012
2	Intravenous Injections 02/2010 - 04/2002
2	Punctures 06/2003 - 04/2002
1	Thrombolytic Therapy 12/2022
1	Aftercare (After-Treatment) 01/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022
1	Noninvasive Ventilation 01/2022
1	Mechanical Ventilators (Ventilator) 01/2021